283 related articles for article (PubMed ID: 12479648)
1. Peroxisome proliferator-activated receptor gamma agonist ligands stimulate a Th2 cytokine response and prevent acute colitis.
Saubermann LJ; Nakajima A; Wada K; Zhao S; Terauchi Y; Kadowaki T; Aburatani H; Matsuhashi N; Nagai R; Blumberg RS
Inflamm Bowel Dis; 2002 Sep; 8(5):330-9. PubMed ID: 12479648
[TBL] [Abstract][Full Text] [Related]
2. Ligands for peroxisome proliferator-activated receptors alpha and gamma inhibit chemically induced colitis and formation of aberrant crypt foci in rats.
Tanaka T; Kohno H; Yoshitani S; Takashima S; Okumura A; Murakami A; Hosokawa M
Cancer Res; 2001 Mar; 61(6):2424-8. PubMed ID: 11289109
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor gamma plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo.
Asakawa M; Takano H; Nagai T; Uozumi H; Hasegawa H; Kubota N; Saito T; Masuda Y; Kadowaki T; Komuro I
Circulation; 2002 Mar; 105(10):1240-6. PubMed ID: 11889020
[TBL] [Abstract][Full Text] [Related]
4. The effect of activation of peroxisome proliferator-activated receptor gamma (PPARgamma) on human monocyte function: PPARgamma ligands do not inhibit tumor necrosis factor-alpha release in human monocytic cell line THP-1.
Naitoh T; Kitahara M; Tsuruzoe N
Cell Biol Toxicol; 2000; 16(2):131-5. PubMed ID: 10917568
[TBL] [Abstract][Full Text] [Related]
5. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.
Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT
Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998
[TBL] [Abstract][Full Text] [Related]
6. Pioglitazone, a PPAR-gamma ligand, provides protection from dextran sulfate sodium-induced colitis in mice in association with inhibition of the NF-kappaB-cytokine cascade.
Takagi T; Naito Y; Tomatsuri N; Handa O; Ichikawa H; Yoshida N; Yoshikawa T
Redox Rep; 2002; 7(5):283-9. PubMed ID: 12688511
[TBL] [Abstract][Full Text] [Related]
7. Troglitazone, a ligand for peroxisome proliferator-activated receptor gamma, inhibits chemically-induced aberrant crypt foci in rats.
Kohno H; Yoshitani S; Takashima S; Okumura A; Hosokawa M; Yamaguchi N; Tanaka T
Jpn J Cancer Res; 2001 Apr; 92(4):396-403. PubMed ID: 11346461
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies.
Desreumaux P; Dubuquoy L; Nutten S; Peuchmaur M; Englaro W; Schoonjans K; Derijard B; Desvergne B; Wahli W; Chambon P; Leibowitz MD; Colombel JF; Auwerx J
J Exp Med; 2001 Apr; 193(7):827-38. PubMed ID: 11283155
[TBL] [Abstract][Full Text] [Related]
9. PPARgamma agonists inhibit cell growth and suppress the expression of cyclin D1 and EGF-like growth factors in ras-transformed rat intestinal epithelial cells.
Kitamura S; Miyazaki Y; Hiraoka S; Nagasawa Y; Toyota M; Takakura R; Kiyohara T; Shinomura Y; Matsuzawa Y
Int J Cancer; 2001 Nov; 94(3):335-42. PubMed ID: 11745411
[TBL] [Abstract][Full Text] [Related]
10. Ligands for peroxisome proliferator-activated receptor gamma inhibit growth and induce apoptosis of human papillary thyroid carcinoma cells.
Ohta K; Endo T; Haraguchi K; Hershman JM; Onaya T
J Clin Endocrinol Metab; 2001 May; 86(5):2170-7. PubMed ID: 11344222
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease.
Adachi M; Kurotani R; Morimura K; Shah Y; Sanford M; Madison BB; Gumucio DL; Marin HE; Peters JM; Young HA; Gonzalez FJ
Gut; 2006 Aug; 55(8):1104-13. PubMed ID: 16547072
[TBL] [Abstract][Full Text] [Related]
12. Thiazolidinedione derivatives as novel therapeutic agents to prevent the development of chronic pancreatitis.
Shimizu K; Shiratori K; Hayashi N; Kobayashi M; Fujiwara T; Horikoshi H
Pancreas; 2002 Mar; 24(2):184-90. PubMed ID: 11854624
[TBL] [Abstract][Full Text] [Related]
13. Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazone.
Camp HS; Li O; Wise SC; Hong YH; Frankowski CL; Shen X; Vanbogelen R; Leff T
Diabetes; 2000 Apr; 49(4):539-47. PubMed ID: 10871190
[TBL] [Abstract][Full Text] [Related]
14. Thiazolidinediones, peroxisome proliferator-activated receptor gamma agonists, regulate endothelial cell growth and secretion of vasoactive peptides.
Fukunaga Y; Itoh H; Doi K; Tanaka T; Yamashita J; Chun TH; Inoue M; Masatsugu K; Sawada N; Saito T; Hosoda K; Kook H; Ueda M; Nakao K
Atherosclerosis; 2001 Sep; 158(1):113-9. PubMed ID: 11500181
[TBL] [Abstract][Full Text] [Related]
15. Troglitazone and related compounds: therapeutic potential beyond diabetes.
Fujiwara T; Horikoshi H
Life Sci; 2000 Oct; 67(20):2405-16. PubMed ID: 11065164
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis.
Feinstein DL; Galea E; Gavrilyuk V; Brosnan CF; Whitacre CC; Dumitrescu-Ozimek L; Landreth GE; Pershadsingh HA; Weinberg G; Heneka MT
Ann Neurol; 2002 Jun; 51(6):694-702. PubMed ID: 12112074
[TBL] [Abstract][Full Text] [Related]
17. Comparison of anti-inflammatory properties of peroxisome proliferator-activated receptor gamma agonists rosiglitazone and troglitazone in prophylactic treatment of experimental colitis.
Celinski K; Dworzanski T; Fornal R; Korolczuk A; Madro A; Brzozowski T; Slomka M
J Physiol Pharmacol; 2013 Oct; 64(5):587-95. PubMed ID: 24304573
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment with troglitazone decreases lethality during endotoxemia in mice.
Reynolds K; Novosad B; Hoffhines A; Gipson J; Johnson J; Peters J; Gonzalez F; Gimble J; Hill M
J Endotoxin Res; 2002; 8(4):307-14. PubMed ID: 12230920
[TBL] [Abstract][Full Text] [Related]
19. Down-Regulation of prostate-specific antigen expression by ligands for peroxisome proliferator-activated receptor gamma in human prostate cancer.
Hisatake JI; Ikezoe T; Carey M; Holden S; Tomoyasu S; Koeffler HP
Cancer Res; 2000 Oct; 60(19):5494-8. PubMed ID: 11034093
[TBL] [Abstract][Full Text] [Related]
20. Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor gamma (PPARgamma) agonists. PPARgamma co-association with transcription factor NFAT.
Yang XY; Wang LH; Chen T; Hodge DR; Resau JH; DaSilva L; Farrar WL
J Biol Chem; 2000 Feb; 275(7):4541-4. PubMed ID: 10671476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
